Raychaudhuri, S., Othus, M., Percival, M.-E., Garcia-Manero, G., Appelbaum, F. R., Erba, H. P., & Appelbaum, J. (2024). Treatment discontinuation due to toxicity for patients with acute myeloid leukemia (AML) treated on SWOG S1203. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Raychaudhuri, Suravi, Megan Othus, Mary-Elizabeth M. Percival, Guillermo Garcia-Manero, Frederick R. Appelbaum, Harry Paul Erba, and Jacob Appelbaum. “Treatment discontinuation due to toxicity for patients with acute myeloid leukemia (AML) treated on SWOG S1203.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Raychaudhuri S, Othus M, Percival M-EM, Garcia-Manero G, Appelbaum FR, Erba HP, et al. Treatment discontinuation due to toxicity for patients with acute myeloid leukemia (AML) treated on SWOG S1203. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Raychaudhuri, Suravi, et al. “Treatment discontinuation due to toxicity for patients with acute myeloid leukemia (AML) treated on SWOG S1203.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Raychaudhuri S, Othus M, Percival M-EM, Garcia-Manero G, Appelbaum FR, Erba HP, Appelbaum J. Treatment discontinuation due to toxicity for patients with acute myeloid leukemia (AML) treated on SWOG S1203. JOURNAL OF CLINICAL ONCOLOGY. 2024.